Correlation Between Pharmaceuticals Ultrasector and Mid-cap Profund
Can any of the company-specific risk be diversified away by investing in both Pharmaceuticals Ultrasector and Mid-cap Profund at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmaceuticals Ultrasector and Mid-cap Profund into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharmaceuticals Ultrasector Profund and Mid Cap Profund Mid Cap, you can compare the effects of market volatilities on Pharmaceuticals Ultrasector and Mid-cap Profund and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmaceuticals Ultrasector with a short position of Mid-cap Profund. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmaceuticals Ultrasector and Mid-cap Profund.
Diversification Opportunities for Pharmaceuticals Ultrasector and Mid-cap Profund
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Pharmaceuticals and Mid-cap is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Pharmaceuticals Ultrasector Pr and Mid Cap Profund Mid Cap in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mid Cap Profund and Pharmaceuticals Ultrasector is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmaceuticals Ultrasector Profund are associated (or correlated) with Mid-cap Profund. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mid Cap Profund has no effect on the direction of Pharmaceuticals Ultrasector i.e., Pharmaceuticals Ultrasector and Mid-cap Profund go up and down completely randomly.
Pair Corralation between Pharmaceuticals Ultrasector and Mid-cap Profund
Assuming the 90 days horizon Pharmaceuticals Ultrasector Profund is expected to generate 1.96 times more return on investment than Mid-cap Profund. However, Pharmaceuticals Ultrasector is 1.96 times more volatile than Mid Cap Profund Mid Cap. It trades about 0.27 of its potential returns per unit of risk. Mid Cap Profund Mid Cap is currently generating about 0.21 per unit of risk. If you would invest 2,210 in Pharmaceuticals Ultrasector Profund on April 28, 2025 and sell it today you would earn a total of 210.00 from holding Pharmaceuticals Ultrasector Profund or generate 9.5% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Pharmaceuticals Ultrasector Pr vs. Mid Cap Profund Mid Cap
Performance |
Timeline |
Pharmaceuticals Ultrasector |
Mid Cap Profund |
Pharmaceuticals Ultrasector and Mid-cap Profund Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pharmaceuticals Ultrasector and Mid-cap Profund
The main advantage of trading using opposite Pharmaceuticals Ultrasector and Mid-cap Profund positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmaceuticals Ultrasector position performs unexpectedly, Mid-cap Profund can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mid-cap Profund will offset losses from the drop in Mid-cap Profund's long position.Pharmaceuticals Ultrasector vs. Qs Large Cap | Pharmaceuticals Ultrasector vs. Fidelity Large Cap | Pharmaceuticals Ultrasector vs. Jpmorgan Large Cap | Pharmaceuticals Ultrasector vs. Astonherndon Large Cap |
Mid-cap Profund vs. Principal Fds Money | Mid-cap Profund vs. John Hancock Money | Mid-cap Profund vs. General Money Market | Mid-cap Profund vs. Fidelity Money Market |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |